RLMD
Relmada Therapeutics, Inc. Common Stock
$6.78
-5.13%
-0.37
Notify me if price changes either direction
Buy RLMD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
718.5M
Enterprise value
-34178432
Trailing PE
-4.7241378652638
Forward PE
-17.585365
PEG Ratio
0.076111110051473
Enterprise to EBITDA
2.467
Price to book MRQ
6.11017
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
EBITDA
-13855048
Diluted EPS TTM
-1.09
Total Cash (MRQ)
116.4M
Current ratio (MRQ)
80.214
Operating Cash Flow (TTM)
-12092784
RLMD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
